These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14127577)

  • 61. Streptomycin action: greater inhibition of Escherichia coli ribosome function with exogenous than with endogenous messenger ribonucleic acid.
    Luzzatto L; Apirion D; Schlessinger D
    J Bacteriol; 1969 Jul; 99(1):206-9. PubMed ID: 4895843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interrelation between guanosine tetraphosphate accumulation, ribonucleic acid synthesis, and streptomycin lethality in Escherichia coli CP78.
    Sakai TT; Cohen SS
    Antimicrob Agents Chemother; 1975 Jun; 7(6):730-5. PubMed ID: 1098569
    [TBL] [Abstract][Full Text] [Related]  

  • 63. STREPTOMYCINOID ANTIBIOTICS: SYNERGISM BY PUROMYCIN.
    WHITE JR; WHITE HL
    Science; 1964 Nov; 146(3645):772-4. PubMed ID: 14197563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MECHANISMS OF ANTIBIOTIC ACTION.
    GALE EF
    Pharmacol Rev; 1963 Sep; 15():481-530. PubMed ID: 14064356
    [No Abstract]   [Full Text] [Related]  

  • 65. NEW TYPE OF STREPTOMYCIN RESISTANCE RESULTING FROM ACTION OF THE EPISOMELIKE MUTATOR FACTOR IN ESCHERICHIA COLI.
    GUNDERSEN WB
    J Bacteriol; 1963 Sep; 86(3):510-6. PubMed ID: 14066430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. STIMULATION AND INHIBITION OF POLYPEPTIDE SYNTHESIS BY STREPTOMYCIN IN RIBOSOMAL SYSTEMS OF ESCHERICHIA COLI, PROGRAMMED WITH VARIOUS MESSENGERS.
    VAN KNIPPENBERGP ; VAN CLAASENJ ; GRIJM-VOS M; VELDSTRA H; BOSCH L
    Biochim Biophys Acta; 1965 Mar; 95():461-73. PubMed ID: 14342538
    [No Abstract]   [Full Text] [Related]  

  • 67. COMPARATIVE MUTABILITY OF NORMAL AND MUTATOR STRAINS OF ESCHERICHIA COLI AND SALMONELLA TYPHIMURIUM EXPOSED TO STREPTOMYCIN, PENICILLIN, POLYMYXIN, COLISTIN, AND TETRACYCLINE.
    KOCH HJ; BRYSON V
    Antimicrob Agents Chemother (Bethesda); 1963; 15():430-3. PubMed ID: 14275486
    [No Abstract]   [Full Text] [Related]  

  • 68. [STUDY OF THE ANTIBIOTIC EFFECT OF STREPTOMYCIN IN THE PRESENCE OF ADENOSINE-5-TRIPHOSPHATE (ATP-K+). ELECTRONIC ASPECTS OF THIS ACTION].
    FAGUET M; GOUDOT A
    Ann Inst Pasteur (Paris); 1964 Jan; 106():48-57. PubMed ID: 14131346
    [No Abstract]   [Full Text] [Related]  

  • 69. Accumulation of label from C14-streptomycin by Escherichia coli.
    HURWITZ C; ROSANO CL
    J Bacteriol; 1962 Jun; 83(6):1193-201. PubMed ID: 14450179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ELECTRON-TRANSPORT COMPONENTS OF STREPTOMYCIN-DEPENDENT ESCHERICHIA COLI.
    BRAGG PD; POLGLASE WJ
    J Bacteriol; 1963 Sep; 86(3):544-7. PubMed ID: 14066434
    [TBL] [Abstract][Full Text] [Related]  

  • 71. NITROFURAN DERIVATIVES AS RADIOMIMETIC AGENTS: CROSS-RESISTANCE STUDIES WITH ESCHERICHIA COLI.
    MCCALLA DR
    Can J Microbiol; 1965 Apr; 11():185-91. PubMed ID: 14323030
    [No Abstract]   [Full Text] [Related]  

  • 72. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.
    Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH
    FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bactericidal action of streptomycin and comparison with spectinomycin in heterozygotes of Escherichia coli.
    Sparling PF; Davis BD
    Antimicrob Agents Chemother; 1972 Mar; 1(3):252-8. PubMed ID: 4261554
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FORMATION OF VALINE BY STREPTOMYCIN-DEPENDENT ESCHERICHIA COLI.
    BRAGG PD; POLGLASE WJ
    J Bacteriol; 1964 Oct; 88(4):1006-9. PubMed ID: 14219011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. EARLY EFFECTS OF STREPTOMYCIN ON BACILLUS MEGATERIUM.
    HANCOCK R
    J Bacteriol; 1964 Sep; 88(3):633-9. PubMed ID: 14208500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Properties and mode of action of a bactericidal compound (=methylglyoxal) produced by a mutant of Escherichia coli.
    Krymkiewicz N; Diéguez E; Rekarte UD; Zwaig N
    J Bacteriol; 1971 Dec; 108(3):1338-47. PubMed ID: 4945198
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of antibiotics on the in vivo synthesis of messenger ribonucleic acid from the lactose operon of Escherichia coli.
    Dütting D; Hübner L
    Mol Gen Genet; 1972; 116(3):277-90. PubMed ID: 4340140
    [No Abstract]   [Full Text] [Related]  

  • 78. INFLUENCE OF DEOXYRIBONUCLEIC ACID DEGRADATION PRODUCTS AND ORTHOPHOSPHATE ON DEOXYNUCLEOTIDE KINASE ACTIVITY AND DEOXYRIBONUCLEIC ACID SYNTHESIS IN PNEUMOCOCCUS TYPE 3.
    FIRSHEIN W
    J Bacteriol; 1965 Aug; 90(2):327-36. PubMed ID: 14329443
    [TBL] [Abstract][Full Text] [Related]  

  • 79. THE BIOSYNTHESIS OF ALKALINE PHOSPHATASE WITH A PARTICULATE FRACTION OF ESCHERICHIA COLI.
    MANSON LA; PELMONT J; YAPO A; ROCHE C; NISMAN B
    Biochem J; 1965 Apr; 95(1):215-25. PubMed ID: 14333560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ENZYMATIC SYNTHESIS OF RIBONUCLEIC ACID. II. PROPERTIES OF THE DEOXYRIBONUCLEIC ACID-PRIMED REACTION WITH MICROCOCCUS LYSODEIKTICUS RIBONUCLEIC ACID POLYMERASE.
    FOX CF; WEISS SB
    J Biol Chem; 1964 Jan; 239():175-85. PubMed ID: 14114840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.